Artificial Intelligence (AI) in healthcare uses advanced computer programs to do tasks that usually need human thinking. These tasks include looking at medical images, guessing how patients will do, scheduling, and automating office work. In the United States, AI is used more and more in helping doctors make decisions, performing robotic surgeries, and managing patient care. Some machines partly run by AI already help with diagnosis and surgery, and fully independent AI systems that can make medical choices on their own are coming soon.
As AI becomes better, it is harder to know who is responsible when something goes wrong. Current laws about medical mistakes do not fit well with errors caused by AI software combined with machines. AI devices are not people, so they cannot be held legally responsible. Instead, responsibility must fall on makers, doctors, or those who maintain the AI, depending on the case and how independent the AI is.
Erika Sophia Grossbard, a law expert from the University of Miami, says new rules about liability for AI medical devices are urgent. She points out that lawmakers and the Food and Drug Administration (FDA) need to work together to create clear rules before these devices become very common. These rules should make it clear if harm was caused by human mistakes, machine problems, or both. This way, patients hurt by AI can seek justice under medical malpractice or product liability laws.
The legal problems with AI in healthcare are big because AI systems mix physical parts, like robots, with invisible parts, like software. It can be hard to tell if an error happens because of broken hardware, software mistakes, or human actions.
Without clear laws, these questions can slow down justice for injured patients and confuse healthcare groups about their legal risks.
New AI tools also raise worries about openness and control. Many AI systems work like “black boxes,” where even experts cannot see or understand how decisions are made. This makes it hard to check AI actions and find faults, showing a need for rules that require human checks and clear information for users.
Patient privacy is a big worry with more AI use. Healthcare has very private personal data, and AI systems need lots of data to learn and improve. This creates risks of data leaks, misuse, or sharing without permission. Such problems reduce trust and break patient rights.
One example is the 2016 partnership between DeepMind, an AI company, and the Royal Free London NHS Foundation Trust. They used AI to detect kidney problems, but the project drew criticism because patient data was shared without proper legal approval, and data control moved beyond the UK’s rules. This case shows the risks of sharing large amounts of data with private companies, raising questions about consent, privacy protection, and legal jurisdiction.
In the U.S., hospitals sometimes share data with tech companies like Microsoft and IBM. But this is done without strong steps to hide identities, which raises chances that individuals could be identified again. Studies show re-identifying people from anonymized data is often possible. For example, an algorithm found it could identify 85.6% of adults in one study group, causing serious privacy worries.
Privacy experts like Blake Murdoch suggest new rules to protect patients’ control over data. This could include repeated consent where patients can agree or refuse new uses of their data again and again. There are also technical options, like creating fake patient data that does not link to real people, which can help protect privacy while still letting AI improve.
Strong privacy rules and open data control must be part of regulations so patients feel safe sharing their health information with AI.
Compared to Europe, where strict AI rules started in August 2024, the United States is still working on its approach. The FDA oversees many AI tools used in clinics, like software detecting diabetic eye problems. But clear federal laws about AI responsibility and privacy are still limited.
Current U.S. laws mostly apply old rules about medical mistakes, product safety, and data privacy to AI tools. Yet, because AI mixes machines, software, and human choices, these laws do not cover all cases well and leave questions about who is responsible. Legal scholars and healthcare workers ask the government to create clearer rules to keep AI safe as the technology and medical care change.
Healthcare leaders and IT managers must keep up with changes in rules and standard procedures. They should work with lawyers and technology providers to check that AI tools in their facilities are safe, clear, and respect privacy.
AI is not just for medical tests or treatments; it also helps office work run more smoothly. In the U.S., AI tools can make front-desk tasks easier for medical offices, cutting staff workload and improving patient service.
Companies like Simbo AI offer phone answering and automation tailored for healthcare. These systems manage appointments, patient questions, reminders, and triage. Automating these tasks helps work go faster, reduces mistakes, and frees staff to focus on important patient care.
Good workflow automation means the right information is ready when needed, which helps make better decisions and lowers delays in care. From safety and legal views, automated systems can keep better records of patient talks and consents, which may help meet rules and avoid legal problems.
AI tools that predict how many patients will come and needed resources also help hospitals plan staff and manage their capacity well. This cuts overbooking, long waits, and staff burnout—all things that affect patient safety and quality care.
For medical administrators, owners, and IT staff in the U.S., dealing with AI technology needs both tech knowledge and understanding of the rules. It is important to:
Being proactive helps healthcare groups keep patients safe while using AI for better diagnosis, treatment, and office efficiency.
AI in healthcare can help improve patient results, lower costs, and make better use of resources. But patient safety and trust depend on clear rules that say who is responsible when AI makes mistakes or causes harm. The U.S. needs to catch up with other places that have clearer AI oversight, privacy rules, and liability standards.
Good rules will give healthcare workers and AI makers a clear path to innovate safely, show their legal risks, and help prevent harm. Meanwhile, administrators and IT staff should use AI carefully, making sure it follows rules, is open, and includes human checks.
Understanding the complex nature of AI in healthcare will help all involved work toward a future where technology supports medicine responsibly, helping patients and providers alike.
As AI-driven healthcare evolves, there is a crucial need for regulations that protect patient safety when automated medical devices cause harm.
The law is unclear on how to allocate liability among stakeholders when an autonomous AI medical device injures a patient during treatment.
Semi-autonomous robots are already diagnosing conditions and performing surgeries, while fully autonomous AI providers are expected to make independent medical decisions.
Lawmakers, in cooperation with the FDA, should create regulations and a liability framework for autonomous AI medical devices before widespread adoption occurs.
A liability scheme needs to reflect the complexities of injuries arising from human errors and machine malfunctions, allowing recovery under malpractice or product liability.
The complexity stems from the interaction of tangible hardware and intangible algorithms in AI medical devices, making it difficult to pinpoint legal responsibility.
AI medical devices themselves lack legal standing, so liability must be assigned to responsible parties like manufacturers, medical providers, and maintenance personnel.
The level of autonomy in an incident will influence how liability is distributed among medical providers, manufacturers, and maintenance staff.
Policymakers should consider societal, policy, and ethical factors to create a framework that promotes tort law objectives while enabling technological innovation.
Proactive regulation will help product developers and medical providers understand their legal exposure, thereby facilitating harm mitigation efforts.